Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and Safety

Learning Objectives After completing this course, the reader will be able to: Compare the response rate of ILP with melphalan and TNF to the response rate of ILP with single‐agent melphalan in patients with unresectable locally advanced melanoma of the limbs. Compare the clinical response rates of r...

Full description

Saved in:

Bibliographic Details
Published in:	The oncologist (Dayton, Ohio) Vol. 15; no. 4; pp. 416 - 427
Main Authors:	Moreno‐Ramirez, David, Cruz‐Merino, Luis, Ferrandiz, Lara, Villegas‐Portero, Roman, Nieto‐Garcia, Adoracion
Format:	Journal Article
Language:	English
Published:	Durham, NC, USA AlphaMed Press 01-04-2010
Subjects:	Antineoplastic Agents, Alkylating - administration & dosage Antineoplastic Agents, Alkylating - therapeutic use Chemotherapy Chemotherapy, Cancer, Regional Perfusion - adverse effects Chemotherapy, Cancer, Regional Perfusion - methods Chemotherapy, Cancer, Regional Perfusion - statistics & numerical data Disease Progression Extremities Humans Isolated limb perfusion Malignant melanoma Melanoma - drug therapy Melanoma - mortality Melanoma - pathology Melanoma and Cutaneous Malignancies Melphalan Melphalan - administration & dosage Melphalan - therapeutic use Spain Treatment Outcome Tumor necrosis factor Spain
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!